Skip to main content
SpringerLink
Log in

Achievement of good long-term control with direct oral anticoagulant for Buerger’s disease

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cacione DG, Macedo CR, do Carmo Novaes F, Baptista-Silva JC. Pharmacological treatment for Buerger’s disease. Cochrane Database Syst Rev 2020; 5: Cd011033.

    PubMed  Google Scholar 

  2. Watanabe Y, Miyata T, Shigematsu K, Tanemoto K, Nakaoka Y, Harigai M. Current trends in epidemiology and clinical features of thromboangiitis obliterans in japan- a nationwide survey using the medical support system database. Circ J 2020; 84: 1786–96.

    Article  PubMed  Google Scholar 

  3. Mills JL, Sr. Buerger’s disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003; 16: 179–89.

    Article  PubMed  Google Scholar 

  4. Shionoya S. Buerger’s disease: diagnosis and management. Cardiovasc Surg 1993; 1: 207–14.

    Article  CAS  PubMed  Google Scholar 

  5. Olin JW, Shih A. Thromboangiitis obliterans (Buerger’s disease). Curr Opin Rheumatol 2006; 18: 18–24.

    Article  PubMed  Google Scholar 

  6. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger’s disease. Eur J Vasc Endovasc Surg 1996; 11: 335–9.

    Article  CAS  PubMed  Google Scholar 

  7. Heestermans M, Poenou G, Hamzeh-Cognasse H, Cognasse F, Bertoletti L. Anticoagulants: a short history, their mechanism of action, pharmacology, and indications. Cell 2022; 11: 3214.

    Article  CAS  Google Scholar 

  8. Sho Y, Sakai T, Matsuda-Hirose H, Yamate T, Hatano Y. Thromboembolism and bleeding in patients with autoimmune blistering disease. Clin Exp Dermatol 2022; 47: 2255–60.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Faculty of Medicine, Oita University, Yufu-shi, Oita, Japan

    Sayuri Miyazaki, Takashi Sakai, Yusuke Nakamura, Tomoko Shono, Kumi Uchimura & Yutaka Hatano

  2. Department of Dermatology, Oita Prefectural Hospital, Oita-shi, Oita, Japan

    Sayuri Miyazaki, Takashi Sakai, Yusuke Nakamura, Tomoko Shono & Kumi Uchimura

Authors
  1. Sayuri Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yusuke Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomoko Shono
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kumi Uchimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yutaka Hatano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takashi Sakai.

Ethics declarations

Conflicts of interest. none.

Additional information

Financial support: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyazaki, S., Sakai, T., Nakamura, Y. et al. Achievement of good long-term control with direct oral anticoagulant for Buerger’s disease. Eur J Dermatol 33, 556–558 (2023). https://doi.org/10.1684/ejd.2023.4567

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2023.4567

Search

Navigation